MELA, GIUSEPPE
 Distribuzione geografica
Continente #
EU - Europa 6.043
AS - Asia 207
SA - Sud America 29
NA - Nord America 16
AF - Africa 2
Totale 6.297
Nazione #
IT - Italia 6.040
SG - Singapore 78
CN - Cina 69
VN - Vietnam 50
BR - Brasile 20
US - Stati Uniti d'America 7
AR - Argentina 6
MX - Messico 5
HK - Hong Kong 4
BD - Bangladesh 3
CA - Canada 3
EC - Ecuador 2
EG - Egitto 2
BG - Bulgaria 1
DO - Repubblica Dominicana 1
GB - Regno Unito 1
IE - Irlanda 1
IN - India 1
IQ - Iraq 1
JP - Giappone 1
VE - Venezuela 1
Totale 6.297
Città #
Genova 3.816
Genoa 1.295
Rapallo 562
Vado Ligure 363
Singapore 25
Beijing 23
Ho Chi Minh City 21
Hanoi 10
Mexico City 5
Hong Kong 4
Rome 3
Tianjin 3
Da Nang 2
Haiphong 2
Hải Dương 2
Montreal 2
Orem 2
Quito 2
Quảng Ngãi 2
Andradina 1
Ashburn 1
Atibaia 1
Baghdad 1
Bordighera 1
Brasília 1
Britânia 1
Brooklyn 1
Bắc Giang 1
Changsha 1
Chapecó 1
Chennai 1
Dublin 1
Fantino 1
Florianópolis 1
Formosa 1
Guangzhou 1
Irecê 1
Isidro Casanova 1
Ituzaingó 1
Nha Trang 1
Ninh Bình 1
Niterói 1
Oklahoma City 1
Palhoça 1
Pirapozinho 1
Poplar 1
Porto Alegre 1
Porto Velho 1
Posadas 1
Recife 1
Resistencia 1
Rio de Janeiro 1
Salvador 1
San Juan Bautista 1
San Rafael de Onoto 1
Sofia 1
Sohag 1
Sorocaba 1
Suzano 1
São Joaquim de Bicas 1
São José do Rio Preto 1
São Paulo 1
Tanta 1
Thái Bình 1
Thái Nguyên 1
Tokyo 1
Vinh 1
Zhengzhou 1
Totale 6.193
Nome #
A pharmacodynamic study of two omeprazole regimens suitable for long-term treatment of duodenal ulcer. 190
Circadian pattern of intragastric acidity in patients with non-erosive reflux disease (NERD) 183
A comparison of the effects on intragastric acidity of bedtime or dinnertime administration of a once daily dose of famotidine. 176
24-hour gastric pH and extent of duodenal gastric metaplasia in Helicobacter pylori-positive patients. 162
Are duodenal ulcer seasonal fluctuations paralleled by seasonal changes in 24-hour gastric acidity and Helicobacter pylori infection? 161
A comparison of five maintenance therapies for reflux esophagitis 159
High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule 157
Acid and gastric metaplasia in the duodenum 156
Antimony and glass pH electrodes can be used interchangeably in 24-hour studies of gastric acidity. 155
Antisecretory effects of three omeprazole regimens for maintenance treatment in duodenal ulcer. 155
Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine. 154
New insight in the mechanism of omeprazole antimicrobial combinations to eradicate Helicobacter pylori. 150
Circadian acidity pattern in prepyloric ulcers: a comparison with normal subjects and duodenal ulcer patients. 147
Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring. 146
Low bedtime doses of H2-receptor antagonists for acute treatment of duodenal ulcer. 144
Circadian gastric acidity in Helicobacter pylori positive ulcer patients with and without gastric metaplasia in the duodenum. 144
24-hour study of gastric acidity in normal subjects and in cholecystectomized patients using continuous pH monitoring. 136
Antisecretory effect of three premeal doses of cimetidine 400 mg versus a single morning dose of omeprazole 20 mg: pathophysiological implications for duodenal ulcer treatment. 134
24-hour gastric pH-metry analysis: influence of arbitrarily predefined time intervals on the reliability of acidity indexes. 126
Evaluation of 24-hour gastric acidity in patients with hepatic cirrhosis. 122
Clinical relevance of sampling rate in the characterization and analysis of 24-hour gastric acidity. A report on 413 cases. 122
Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording. 121
[Esophageal pH monitoring: factors influencing the definition of normality]. 121
The effects of omeprazole 20 and 40 mg twice daily on intragastric acidity in duodenal ulcer patients. 121
Is gastric acid hypersecretion the only reason for refractory gastroesophageal reflux disease? 115
Comparison of 24-h control of gastric acidity by three different dosages of pantoprazole in patients with duodenal ulcer. 114
Analysis of circadian fluctuations of bile salt concentration and pH in the stomach of normal subjects and patients suspected of having duodenogastric reflux. 114
Ulcer healing: does omeprazole efficacy depend on daytime or 24-hour acid inhibition? 113
Once-Daily Bedtime Dose of Roxatidine and Ranitidine in Acute Duodenal Ulcer: A Combined Assessment of Acid Inhibitory Activity and Healing Rate. 110
Circadian gastric acidity and Helicobacter pylori infection in patients with chronic pancreatitis. 109
Circadian acidity pattern in gastric ulcers at different sites. 108
Effect of Helicobacter pylori eradication on 24-hour gastric pH and duodenal gastric metaplasia. 105
Duodenal ulcer resistant to usual omeprazole dose. 105
Histological and functional recovery in patients with multifocal atrophic gastritis after eradication of Helicobacter pylori infection. 105
Gastric aspiration versus antimony and glass pH electrodes. A simultaneous comparative in vivo study. 104
Bolus infusion of famotidine: effects on gastric pH by repeated 12-hour doses of 20 mg in postoperative patients. 102
Pharmacodynamics of famotidine in gastric ulcer. 101
Comparison of isotope ratio mass spectrometry and nondispersive isotope-selective infrared spectroscopy for 13C-urea breath test. 101
Head-to-head comparison of 1-week triple regimens combining ranitidine or omeprazole with two antibiotics to eradicate Helicobacter pylori. 101
Single morning and nightly doses of ranitidine 300 mg: an appraisal of their antisecretory effects by continuous pH monitoring. 99
Ulcer heterogeneity: further arguments for a range of antisecretory treatment. 99
Intragastric acidity and serum gastrin after sufotidine. 98
Duration of acid suppression in H2-antagonist nonresponders. 97
Influence of sampling rate in 24 hour gastric pH-metry analysis. 96
Twenty-four-hour control of gastric acidity by twice-daily doses of placebo, nizatidine 150 mg, nizatidine 300 mg, and ranitidine 300 mg. 94
Lack of gastric acid rebound after stopping a successful short-term course of nizatidine in duodenal ulcer patients. 92
Once or twice daily doses of proton pump inhibitor in treating Barrett's esophagus? 90
Mealtime versus nighttime acid inhibition. A clinical pharmacological study with ranitidine. 89
Continuous acidity monitoring in the study of gastric antisecretory drugs: pH or antilog transformation of pH, mean or median? 83
Overnight comparable anacidity by standard large and half-single bedtime doses of H2 antagonists in duodenal ulcer patients: a clinical pharmacological study. 78
Variability in individual response to various doses of omeprazole. Implications for antiulcer therapy. 77
Effect of one-month treatment with nonsteroidal antiinflammatory drugs (NSAIDs) on gastric pH of rheumatoid arthritis patients. 56
Totale 6.297
Categoria #
all - tutte 18.796
article - articoli 15.438
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 3.358
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.592


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021145 0 0 0 0 0 12 22 16 40 28 15 12
2021/2022539 14 51 25 90 13 40 61 87 25 53 16 64
2022/2023666 66 47 9 63 137 97 0 28 116 3 94 6
2023/2024284 9 34 8 31 16 44 10 11 29 3 30 59
2024/2025888 47 72 23 47 122 92 75 149 31 31 100 99
2025/2026643 199 31 77 147 168 21 0 0 0 0 0 0
Totale 6.297